Collagen Solutions Plc announced it has entered into a new minimum three-year agreement with NovaBone Products (NovaBone), a designer and manufacturer of US FDA-cleared synthetic bone grafts. NovaBone is a long-standing customer of Collagen Solutions. The companies began their collaboration in 2015 to develop and supply specialised collagen biomaterials specific to their line of bone graft products used in orthopedic and dental applications. The agreement formalises a longer-term supply arrangement to ensure NovaBone has consistent and increased access to this specialised material to support their continued growth. NovaBone was recently acquired by Halma Plc (Halma) to enhance Halma's presence in the orthopaedics market and fast-growing biologics segment. Halma is a diversified, blue chip, global group of life-saving technology companies focused on creating a safer, cleaner and healthier future for people worldwide.